Kingswood Wealth Advisors LLC Has $533,000 Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Kingswood Wealth Advisors LLC boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,813 shares of the company’s stock after buying an additional 2,265 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $533,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after buying an additional 251 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter worth about $26,000. Darwin Wealth Management LLC acquired a new stake in GE HealthCare Technologies in the 3rd quarter valued at approximately $31,000. Finally, Continuum Advisory LLC lifted its stake in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Wells Fargo & Company increased their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $87.85 on Thursday. The stock has a market capitalization of $40.14 billion, a PE ratio of 24.13, a PEG ratio of 2.88 and a beta of 1.11. The business’s 50 day simple moving average is $82.61 and its 200 day simple moving average is $84.92. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a one year low of $72.52 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter last year, the firm posted $0.99 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is currently 3.85%.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.